Research interests

Marie José Kersten is a professor of hematology and head of the department of Hematology at the Academic Medical Center in Amsterdam. B cell malignancies are the main focus of research in this department, which together with the departments of Pathology and Experimental Immunology forms the basis for the LYMMCARE Institute (Lymphoma and Myeloma Center Amsterdam). Marie José Kersten is involved in several research projects and she is the principal investigator for several phase I/II clinical trials focusing on the biology and treatment of NHL, Waldenstrom’s macroglobulinemia and Hodgkin lymphoma. She has recently been appointed as chair of the newly established EHA (European Hematology Association) Scientific Working Group Lymphoma. She is the co-chair of the HOVON (Hemato-Oncologie Volwassenen Nederland) Lymphoma Working Party, and a co-founder and member of the Board of the Lunenburg Lymphoma Phase I/II Consortium (LLPC). The main focus of the LLPC is to perform early clinical trials (from first-in-man trials to early phase II trials) in patients with lymphoma. She is also an active member of the Lunenburg Lymphoma Biomarker Consortium (LLBC), the European Waldenstrom’s Macroglobulinemia Consortium (EWMC) and the HOVON Myeloma Working Party. Another research theme within LYMMCARE is to better understand the biology underlying tumor growth, progression and treatment resistance (in lymphoma, Waldenstrom's macroglobulinemia and multiple myeloma). This research is done in collaboration with the pathology department at the AMC (Pals/Spaargaren).


Biology and treatment of lymphoma, with an emphasis on early clinical trials

ID: 65036